Psychosis; schizophrenia; depression with or without anxiety.
Up to 30mg daily [orally]. 20-200mg 1.M every 2-4 weeks.
Mode of action
Brands containing this Ingredient
Drug Index 2.0 is hereOur new update features a more powerful search feature and easier login.
issues? Contact us
today. Contact Us
Mode of Action
It is thought to act by blocking postsynaptic dopamine receptors in the brain. It also produces an alpha-adrenergic blocking effect and depresses the release of most hypothalamic and hypophyseal hormones.
Avoid abrupt withdrawal, extremes of body temperatures, epilepsy and skin contact
Parkinsonism, myasthenia gravis, concomitant use with CNS depressants, diabetes mellitus, bone marrow depression, close angle glaucoma, hepatic, renal, CVS impairment, phaeochromocytosis, hyperthyroidism.